Table of Contents
Research & Development
| Novartis Signs US$1.7 B Deal with Bicycle Therapeutics for Cancer Radiopharmaceuticals | Abstract html pdf |
| Lucy Haggerty |
Licensing
| BioNTech Enters ADC Field with US$1.6 B+ DualityBio Licensing Deal | Abstract pdf html |
| Lucy Haggerty |
| Bristol Myers Squibb Signs US$1 B+ Deal with Tubulis for Solid Tumour ADCs | Abstract pdf html |
| Lucy Haggerty |
Opinion & Analysis
| M&A Activity Starts to Pick up in Q2 2023 | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.